Founded in 2016, Foghorn Therapeutics discovers and develops novel drugs to treat cancer and other serious medical disorders. The company seeks to discover novel therapeutics that target chromatin remodeling complexes. Foghorn uses a proprietary platform based on revolutionary advances in mechanistic understanding of disease.
We are seeking a strong leader for our small molecule drug discovery programs. This individual will work closely with the chemistry, drug discovery, and other functions to drive programs from target conception to IND filing and beyond. The successful candidate will mentor and supervise early-career scientists. He/she will be an important member in the biology group leadership team to build out the scientific and operation strategy of the biological research.